Real-World Outcomes of Nivolumab and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium - Concepedia

Concepedia

Publication | Open Access

Real-World Outcomes of Nivolumab and Cabozantinib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

DOI Full Paper Access

29

Citations

10

References

2019

Year

Igor Stukalin, J. Connor Wells, Jeffrey Graham, Takeshi Yuasa, Benoit Beuselinck, Christian K. Kollmansberger, D. Scott Ernst, N. Agarwal, Thanh Le, Frede Donskov,

Current Oncology

Abstract

Real-world imdc data indicate comparable os and ttf for nivolumab and cabozantinib. Both agents are reasonable therapeutic options for patients progressing after initial first-line vegfr-targeted therapy.

References

	Year	Citations

Page 1